UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000043212 |
|---|---|
| Receipt number | R000049317 |
| Scientific Title | Observational study on thyroid dysfunctions in medullary thyroid carcinoma |
| Date of disclosure of the study information | 2021/02/02 |
| Last modified on | 2022/08/04 17:13:53 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Observational study on thyroid dysfunctions in medullary thyroid carcinoma
Acronym
Thyroid dysfunctions in medullary thyroid carcinoma
Scientific Title
Observational study on thyroid dysfunctions in medullary thyroid carcinoma
Scientific Title:Acronym
Thyroid dysfunctions in medullary thyroid carcinoma
Region
| Japan |
Condition
Condition
Medullary thyroid carcinoma
Classification by specialty
| Endocrinology and Metabolism |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
To clarify the effect of thyroid dysfunctions on the clinical profiles in medullary thyroid cadrcinoma
Basic objectives2
Bio-availability
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Tumor markers on medullary thyroid carcinoma
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| 100 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
Patients who are diagnosed as medullary thyroid carcinoma
Key exclusion criteria
Patients who are not diagnosed as medullary thyroid carcinoma
Target sample size
20
Research contact person
Name of lead principal investigator
| 1st name | Ken |
| Middle name | |
| Last name | Takeshima |
Organization
Wakayama Medical University
Division name
First Department of Internal Medicine
Zip code
641-8509
Address
811-1 Kimi-idera, Wakayama
TEL
0734410625
kt10948@wakayama-med.ac.jp
Public contact
Name of contact person
| 1st name | Ken |
| Middle name | |
| Last name | Takeshima |
Organization
Wakayama Medical University
Division name
First Department of Internal Medicine
Zip code
6418509
Address
811-1 Kimi-idera, Wakayama
TEL
0734410625
Homepage URL
kt10948@wakayama-med.ac.jp
Sponsor or person
Institute
Wakayama Medical University
Institute
Department
Personal name
Funding Source
Organization
Nothing
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Wakayama Medical University Hospital Ethics Committee
Address
811-1 Kimi-idera, Wakayama
Tel
073-441-0867
wa-rinri@wakayama-med.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2021 | Year | 02 | Month | 02 | Day |
Related information
URL releasing protocol
Nothing
Publication of results
Unpublished
Result
URL related to results and publications
Nothing
Number of participants that the trial has enrolled
1
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Terminated
Date of protocol fixation
| 2019 | Year | 06 | Month | 03 | Day |
Date of IRB
| 2020 | Year | 06 | Month | 03 | Day |
Anticipated trial start date
| 2020 | Year | 06 | Month | 03 | Day |
Last follow-up date
| 2022 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
The relationship between thyroid dysfunction and clinical data such as labo data, pathological features, and images.
Management information
Registered date
| 2021 | Year | 02 | Month | 01 | Day |
Last modified on
| 2022 | Year | 08 | Month | 04 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049317
